Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep:158:107955.
doi: 10.1016/j.ijid.2025.107955. Epub 2025 Jun 15.

VIDAS® TB-IGRA assay for diagnosing tuberculosis infection in people living with HIV: A preliminary study

Aliasgar Esmail  1 , Jeremi Swanepoel  1 , Suzette Oelofse  1 , Brandon Reyneke  1 , Anil Pooran  1 , Shameem Jaumdally  1 , Lara Wiese  1 , Keertan Dheda  2
Affiliations
Free article

VIDAS® TB-IGRA assay for diagnosing tuberculosis infection in people living with HIV: A preliminary study

Aliasgar Esmail et al. Int J Infect Dis. 2025 Sep.
Free article

Abstract

Background: The diagnosis of presumed latent tuberculosis (TB) infection (LTBI) is problematic in people living with HIV (PLWH) because of sub-optimal sensitivity and high indeterminate rates, especially in those with advanced immunosuppression. Better diagnostic tools for LTBI are needed in this sub-population.

Methods: We compared the sensitivity of VIDAS TB-IGRA, a fully automated RD1-specific new interferon-ϒ-release assay (IGRA), to QFT-Plus in 77 PLWH with active pulmonary TB who had varying CD4 counts. Sputum culture positivity served as the reference standard for active TB.

Results: The sensitivity of VIDAS TB-IGRA was similar to QFT-Plus overall [90.9% (70/77) vs 92.0% (69/75)], in those with CD4 <200 cells/mm3, [88.9% (40/45) vs 88.6% (39/44)], and in those with CD4 <100 [85.7% (18/21) vs 80.0% (16/20)]. However, VIDAS TB-IGRA had a higher sensitivity in those with CD4 <50 [92.3% (12/13) vs 75% (9/12)] and fewer indeterminate results overall [0 vs 2]. When the indeterminate results in this subgroup were regarded as negative, the comparative sensitivity was [92.3% (12/13) vs 69.2% (9/13)].

Conclusion: VIDAS TB-IGRA had a similar sensitivity to QFT-Plus in PLWH. Whether VIDAS TB-IGRA sensitivity is significantly better at lower CD4 counts remains to be confirmed in a larger study. These data have implications for the diagnosis of LTBI in those with advanced immunosuppression.

Keywords: Active TB; Diagnosis; Interferon-gamma release assay (IGRA); Latent TB infection; Tuberculosis.

PubMed Disclaimer